Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others.

about

The self-disproportionation of enantiomers (SDE): a menace or an opportunity?Synthesis of fluoro-functionalized diaryl-λ3-iodonium salts and their cytotoxicity against human lymphoma U937 cells.

P2860

Q52575919-B8BA1078-F071-4B1E-A469-33853FB0669C Q52728708-1A444E5F-500D-4105-B056-85A20F958ECB

P2860

Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others.

Item

http://www.wikidata.org/entity/Q38649220

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Biological evaluation of both ...... oma cell line H929 and others.

@en

type

Item

label

Biological evaluation of both ...... oma cell line H929 and others.

@en

prefLabel

Biological evaluation of both ...... oma cell line H929 and others.

@en

P1476

Biological evaluation of both ...... loma cell line H929 and others

@en

P2093

Etsuko Tokunaga

http://www.w3.org/2001/XMLSchema#string

Hideaki Hara

http://www.w3.org/2001/XMLSchema#string

Hidehiko Akiyama

http://www.w3.org/2001/XMLSchema#string

Vadim A Soloshonok

http://www.w3.org/2001/XMLSchema#string

Yuki Inoue

http://www.w3.org/2001/XMLSchema#string

P2860

Ripped to death

Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells

Old, new and emerging functions of caspases.

BCL-2 family members and the mitochondria in apoptosis

Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.

Simulation of Human Plasma Concentrations of Thalidomide and Primary 5-Hydroxylated Metabolites Explored with Pharmacokinetic Data in Humanized TK-NOG Mice.

Thalidomide for previously untreated indolent or smoldering multiple myeloma.

Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase.

Mechanism of action in thalidomide teratogenesis.

Clinical pharmacokinetics of thalidomide.

P304

e0182152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0182152

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Norio Shibata

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28763493

http://www.w3.org/2001/XMLSchema#string

P921

thalidomide

P932

5538663

http://www.w3.org/2001/XMLSchema#string

Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others.

about

P2860

P2860

Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932